Circular Genomics, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Circular Genomics, Inc. - overview
Established
2021
Location
Albuquerque, NM, US
Primary Industry
Biotechnology
About
Based in New Mexico, US, and founded in 2021 by co-founders Nikolaos Mellios, Alexander Hafez, and Kosmas Karadimitriou, Circular Genomics Inc. operates as a genomics company providing diagnosis and treatment of psychiatric and neurological disorders through development of circular RNA biomarkers. In December 2025, Circular Genomics, Inc. raised USD 15 million in series A funding led by Mountain Group Partners, with participation from Alzheimer's Drug Discovery Foundation, Poplar Grove Investors and HIP Fund.
Circular Genomics Inc. developed a product, that is a blood-based assay that analyzes circular RNA biomarkers to predict a patient's response to selective serotonin reuptake inhibitor (SSRI) antidepressants before treatment initiation. The company’s diagnostic tool expedites treatment by identifying the most effective medication, thereby increasing the likelihood of patient recovery and reducing the trial-and-error approach commonly associated with psychiatric treatment. It uses circular RNA biomarkers to offers a enrichment in neural tissue, allowing for non-invasive, accurate, and dynamic monitoring of brain disorders.
The company will use the December 2025 funding to expand clinical validation, improve its biomarker platform, form partnerships, and hire key team members.
Current Investors
Cottonwood Technology Fund, Mountain Group Partners, Tramway Venture Partners
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Biopharmaceuticals, Diagnostic Equipment
Website
www.circulargenomics.com
Verticals
HealthTech
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.